Indian J Palliat Care Home 
 

REVIEW ARTICLE
Year : 2006  |  Volume : 12  |  Issue : 2  |  Page : 56--64

The role of reirradiation versus chemotherapy in recurrent head and neck cancer

Jenifer Jeba, Reena George 
 Palliative Care Unit, Christian Medical College, Vellore - 632 004, India

Correspondence Address:
Jenifer Jeba
Palliative Care Unit, Christian Medical College, Vellore - 632 004
India

Head and neck cancer recurrences after definitive radiotherapy present a difficult therapeutic problem, as only a small proportion of patients have resectable disease. When surgery is not possible, reirradiation might be a feasible option for selected patients, particularly those with favourable prognostic factors such as second primaries, nasopharyngeal or laryngeal tumours or delayed recurrences. Current evidence indicates that in this group of patients reirradiation offers better control rates than palliative chemotherapy. The loco regional control rates of reirradiation without surgery is 20% at five years and 27% at two years. The overall survival rate with reirradiation ranges from 10% to 35% at two years and 0% to 14.6% at five years. The first randomized trial directly comparing chemotherapy with reirradiation is in progress. This article outlines the indications for and results of reirradiation and chemotherapy in post radiotherapy recurrences of head and neck cancer.


How to cite this article:
Jeba J, George R. The role of reirradiation versus chemotherapy in recurrent head and neck cancer.Indian J Palliat Care 2006;12:56-64


How to cite this URL:
Jeba J, George R. The role of reirradiation versus chemotherapy in recurrent head and neck cancer. Indian J Palliat Care [serial online] 2006 [cited 2020 Jun 2 ];12:56-64
Available from: http://www.jpalliativecare.com/article.asp?issn=0973-1075;year=2006;volume=12;issue=2;spage=56;epage=64;aulast=Jeba;type=0